- Home
- UK
as 12-31-2024 4:00pm EST
Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. They provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has three operating segments: Workspace membership, Marketing and branding services, and Other services. Marketing and branding services generate the majority of the company's revenue.
| Founded: | 2015 | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | 1.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 422.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.16 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.04 - $6.46 | Next Earning Date: | 02-15-2025 |
| Revenue: | $42,470,655 | Revenue Growth: | -51.28% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Ucommune International Ltd News
UK Breaking Stock News: Dive into UK Ticker-Specific Updates for Smart Investing
GlobeNewswire
a year ago
Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option
GlobeNewswire
a year ago
Singularity Future Technology Announces 1-for-10 Reverse Stock Split
Benzinga
a year ago
2024 Promises An EV Evolution With New Clean Energy Solutions
GlobeNewswire
a year ago
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women
Business Wire
a year ago
Biote Announces $20 Million Share Repurchase Authorization
Zacks
a year ago
Lisata (LSTA) Stock Up More Than 35% in 3 Months: Here's Why
GlobeNewswire
a year ago
Surrozen Provides Corporate Update on Clinical Programs
PR Newswire
a year ago
Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
Compare UK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "UK Ucommune International Ltd - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.